{"id":31386,"date":"2017-04-25T00:00:00","date_gmt":"2017-04-24T15:00:00","guid":{"rendered":"https:\/\/rftcjapan.org\/uncategorized\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/"},"modified":"2019-02-08T14:39:46","modified_gmt":"2019-02-08T05:39:46","slug":"new-princess-margaret-cancer-drug-approved-for-clinical-trial-2","status":"publish","type":"post","link":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/","title":{"rendered":"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL"},"content":{"rendered":"<p><a href=\"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-2306\" src=\"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg\" alt=\"Believe-it\" width=\"691\" height=\"266\" \/><\/a><\/p>\n<p>The new drug (CFI-40095) developed by the team led by Drs. Tak Mak of The Campbell Family Cancer Research Institute at the Princess Margaret Cancer Centre, and Dennis Slamon of the University of California, Los Angeles, two of the world\u2019s most acclaimed cancer researchers, has been approved by Health Canada to proceed to Phase 1 clinical trial in Canada. In the lab, the drug has been shown to inhibit the growth of human breast and ovarian cancers as well as colorectal, glioblastoma, lung, melanoma, pancreatic and prostate cancers.\u201d<\/p>\n<p>Key supporters integral to the research and the development of the drug have been the walkers and their donors in the Shoppers Drug Mart\u2122 Weekend To End Women\u2019s Cancers\u00ae, with special thanks to title sponsor, Shoppers Drug Mart, and long-time, robust supporters, CIBC, as well as the Campbell family, the Canadian Institutes of Health Research (CIHR), Genome Canada and The California Institute for Regenerative Medicine (CIRM).<\/p>\n<p>The drug is wholly owned by University Health Network (UHN). It is expected that the clinical trial will begin later this year following approval from UHN\u2019s Research Ethics Board.<\/p>\n<p>We are grateful to all supporters and those involved in reaching this critical milestone.<\/p>\n<p><a title=\"thepmcf\" href=\"http:\/\/thepmcf.us1.list-manage.com\/track\/click?u=aa449736ade3b13ffe2102e4a&amp;id=2b758adf7b&amp;e=3c2aaa2b05\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-2282\" src=\"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/ThePMCF_logo.jpg\" alt=\"Print\" width=\"300\" height=\"59\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The new drug (CFI-40095) developed by the team led by Drs. Tak Mak of The Campbell Family Cancer Research Institute&#8230;<\/p>\n","protected":false},"author":121,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[],"class_list":["post-31386","post","type-post","status-publish","format-standard","hentry","category-pickup-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL - RFTC Japan<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL - RFTC Japan\" \/>\n<meta property=\"og:description\" content=\"The new drug (CFI-40095) developed by the team led by Drs. Tak Mak of The Campbell Family Cancer Research Institute...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/\" \/>\n<meta property=\"og:site_name\" content=\"RFTC Japan\" \/>\n<meta property=\"article:published_time\" content=\"2017-04-24T15:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-08T05:39:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg\" \/>\n<meta name=\"author\" content=\"Marco Magnani\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marco Magnani\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/\"},\"author\":{\"name\":\"Marco Magnani\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/#\\\/schema\\\/person\\\/5fb71c04b0dc2d2feed17e8d55cdeaa6\"},\"headline\":\"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL\",\"datePublished\":\"2017-04-24T15:00:00+00:00\",\"dateModified\":\"2019-02-08T05:39:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/\"},\"wordCount\":208,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rftcjapan.org\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/Believe-it2.jpg\",\"articleSection\":[\"Pickup Article\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/\",\"url\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/\",\"name\":\"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL - RFTC Japan\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rftcjapan.org\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/Believe-it2.jpg\",\"datePublished\":\"2017-04-24T15:00:00+00:00\",\"dateModified\":\"2019-02-08T05:39:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/#\\\/schema\\\/person\\\/5fb71c04b0dc2d2feed17e8d55cdeaa6\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/rftcjapan.org\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/Believe-it2.jpg\",\"contentUrl\":\"https:\\\/\\\/rftcjapan.org\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/Believe-it2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/pickup-article\\\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/\",\"name\":\"RFTC Japan\",\"description\":\"Japan&#039;s Leading Breast Cancer Foundation\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/rftcjapan.org\\\/en\\\/#\\\/schema\\\/person\\\/5fb71c04b0dc2d2feed17e8d55cdeaa6\",\"name\":\"Marco Magnani\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL - RFTC Japan","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/","og_locale":"en_US","og_type":"article","og_title":"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL - RFTC Japan","og_description":"The new drug (CFI-40095) developed by the team led by Drs. Tak Mak of The Campbell Family Cancer Research Institute...","og_url":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/","og_site_name":"RFTC Japan","article_published_time":"2017-04-24T15:00:00+00:00","article_modified_time":"2019-02-08T05:39:46+00:00","og_image":[{"url":"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg","type":"","width":"","height":""}],"author":"Marco Magnani","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marco Magnani","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#article","isPartOf":{"@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/"},"author":{"name":"Marco Magnani","@id":"https:\/\/rftcjapan.org\/en\/#\/schema\/person\/5fb71c04b0dc2d2feed17e8d55cdeaa6"},"headline":"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL","datePublished":"2017-04-24T15:00:00+00:00","dateModified":"2019-02-08T05:39:46+00:00","mainEntityOfPage":{"@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/"},"wordCount":208,"commentCount":0,"image":{"@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#primaryimage"},"thumbnailUrl":"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg","articleSection":["Pickup Article"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/","url":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/","name":"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL - RFTC Japan","isPartOf":{"@id":"https:\/\/rftcjapan.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#primaryimage"},"image":{"@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#primaryimage"},"thumbnailUrl":"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg","datePublished":"2017-04-24T15:00:00+00:00","dateModified":"2019-02-08T05:39:46+00:00","author":{"@id":"https:\/\/rftcjapan.org\/en\/#\/schema\/person\/5fb71c04b0dc2d2feed17e8d55cdeaa6"},"breadcrumb":{"@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#primaryimage","url":"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg","contentUrl":"https:\/\/rftcjapan.org\/wp-content\/uploads\/2014\/02\/Believe-it2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/rftcjapan.org\/en\/pickup-article\/new-princess-margaret-cancer-drug-approved-for-clinical-trial-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rftcjapan.org\/en\/"},{"@type":"ListItem","position":2,"name":"NEW PRINCESS MARGARET CANCER DRUG APPROVED FOR CLINICAL TRIAL"}]},{"@type":"WebSite","@id":"https:\/\/rftcjapan.org\/en\/#website","url":"https:\/\/rftcjapan.org\/en\/","name":"RFTC Japan","description":"Japan&#039;s Leading Breast Cancer Foundation","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rftcjapan.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/rftcjapan.org\/en\/#\/schema\/person\/5fb71c04b0dc2d2feed17e8d55cdeaa6","name":"Marco Magnani"}]}},"_links":{"self":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/posts\/31386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/users\/121"}],"replies":[{"embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/comments?post=31386"}],"version-history":[{"count":0,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/posts\/31386\/revisions"}],"wp:attachment":[{"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/media?parent=31386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/categories?post=31386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rftcjapan.org\/en\/wp-json\/wp\/v2\/tags?post=31386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}